Free Trial

SMX (Security Matters) Public (SMX) Competitors

SMX (Security Matters) Public logo
$0.25 -0.01 (-3.61%)
(As of 01:30 PM ET)

SMX vs. DMAQ, CYD, NVOS, GENC, HLP, MOG-A, STRCW, DHAC, INTE, and ROCL

Should you be buying SMX (Security Matters) Public stock or one of its competitors? The main competitors of SMX (Security Matters) Public include Deep Medicine Acquisition (DMAQ), China Yuchai International (CYD), Novo Integrated Sciences (NVOS), Gencor Industries (GENC), Hongli Group (HLP), Moog (MOG-A), Palladyne AI (STRCW), Digital Health Acquisition (DHAC), Integral Acquisition Co. 1 (INTE), and Roth Ch Acquisition V (ROCL).

SMX (Security Matters) Public vs.

SMX (Security Matters) Public (NASDAQ:SMX) and Deep Medicine Acquisition (NASDAQ:DMAQ) are both small-cap business services companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, risk, earnings, analyst recommendations, valuation, community ranking, media sentiment, institutional ownership and profitability.

Company Net Margins Return on Equity Return on Assets
SMX (Security Matters) PublicN/A N/A N/A
Deep Medicine Acquisition N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SMX (Security Matters) PublicN/AN/A-$20.91MN/AN/A
Deep Medicine AcquisitionN/AN/AN/AN/AN/A

SMX (Security Matters) Public and Deep Medicine Acquisition both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
SMX (Security Matters) PublicN/AN/A
Deep Medicine AcquisitionN/AN/A

SMX (Security Matters) Public has a beta of -1.92, suggesting that its stock price is 292% less volatile than the S&P 500. Comparatively, Deep Medicine Acquisition has a beta of 0.02, suggesting that its stock price is 98% less volatile than the S&P 500.

15.7% of SMX (Security Matters) Public shares are held by institutional investors. Comparatively, 18.4% of Deep Medicine Acquisition shares are held by institutional investors. 9.4% of SMX (Security Matters) Public shares are held by insiders. Comparatively, 1.7% of Deep Medicine Acquisition shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

In the previous week, SMX (Security Matters) Public's average media sentiment score of 0.00 equaled Deep Medicine Acquisition'saverage media sentiment score.

Company Overall Sentiment
SMX (Security Matters) Public Neutral
Deep Medicine Acquisition Neutral

Summary

Deep Medicine Acquisition beats SMX (Security Matters) Public on 2 of the 3 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SMX vs. The Competition

MetricSMX (Security Matters) Publicindustrial & commercial machinery & equipment IndustryBusiness SectorNASDAQ Exchange
Market Cap$708,000.00$23.81B$6.59B$8.80B
Dividend YieldN/A0.47%2.93%4.07%
P/E RatioN/A19.5235.6713.60
Price / SalesN/A10.24171.6687.40
Price / CashN/A26.0626.3736.27
Price / Book0.003.714.886.33
Net Income-$20.91M$546.32M$123.37M$225.93M
7 Day Performance-9.88%-2.09%0.13%-0.96%
1 Month Performance-90.37%-11.50%8.37%1.06%
1 Year Performance-99.71%17.93%31.33%26.59%

SMX (Security Matters) Public Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SMX
SMX (Security Matters) Public
0.063 of 5 stars
$0.25
-3.6%
N/A-99.7%$729,000.00N/A0.00N/A
DMAQ
Deep Medicine Acquisition
N/A$0.44
+2.3%
N/A-96.2%$1.92MN/A0.0093Gap Down
High Trading Volume
CYD
China Yuchai International
N/A$9.44
+3.2%
N/A-2.8%$2.55M$2.55B0.008,177
NVOS
Novo Integrated Sciences
0.7344 of 5 stars
$0.06
-5.2%
N/A-96.3%$1.09M$12.57M0.00127Gap Down
GENC
Gencor Industries
N/A$21.27
-0.3%
N/A+48.8%$0.00$105.07M19.35370
HLP
Hongli Group
N/A$1.25
-1.6%
N/A-73.1%$0.00$14.05M0.00207
MOG-A
Moog
N/A$217.08
-0.5%
$141.00
-35.0%
+60.5%$0.00N/A26.2214,000High Trading Volume
STRCW
Palladyne AI
N/A$0.05
+123.0%
N/A+135.0%$0.00N/A0.0070Gap Up
High Trading Volume
DHAC
Digital Health Acquisition
N/A$1.32
-1.5%
N/A-89.5%$4.76MN/A0.002,021
INTE
Integral Acquisition Co. 1
N/A$10.91
flat
N/AN/A$44.40MN/A0.002
ROCL
Roth Ch Acquisition V
N/A$11.43
+1.0%
N/A+6.1%$56.24MN/A0.007High Trading Volume

Related Companies and Tools


This page (NASDAQ:SMX) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners